ClinConnect ClinConnect Logo
Search / Trial NCT02843672

Operative Treatment Of Metatarsalgia: Triple Weil Osteotomy Or Distal Metatarsal Minimal Invasive Osteotomy (DMMO)?

Launched by MANUEL CUERVAS-MONS · Jul 21, 2016

Trial Information

Current as of April 25, 2025

Unknown status

Keywords

Metatarsalgia Surgery Weil Mis Percutaneous Dmmo

ClinConnect Summary

INTRODUCTION

Metatarsalgia is a vague term defining a symptom instead of a specific condition. The aim of surgical treatment of metatarsalgia is to decrease the pressure under metatarsal head, shortening and / or raising the metatarsal, thus removing the overload and preserving the joint integrity. It has been somewhat controversial, with more than 25 different lesser metatarsal osteotomies described to date. The Weil osteotomy is the most widely used surgical treatment in open distal metatarsal surgery, a popularity based upon the simple technique, stable fixation, excellent union rates a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • all consecutive adult patients with the diagnosis of mechanical metatarsalgia served in the Department of Orthopaedic Surgery and Traumatology of the investigative hospital, without non-operative treatment response after 6 months
  • Exclusion Criteria:
  • traumatic metatarsalgia
  • secondary metatarsalgia (diabetes, rheumatoid arthritis, or general diseases)
  • equinus contracture
  • active infection
  • systematic disease (inflammatory, metabolic, neurologic or vascular) explaining symptoms, - metatarsophalangeal (MTPJ) dislocation higher than 5mm
  • inability to complete postoperative management
  • previous forefoot surgeries

About Manuel Cuervas Mons

Manuel Cuervas-Mons is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic approaches, he leads and oversees clinical trials that aim to evaluate the safety and efficacy of new treatments across various therapeutic areas. His expertise in trial design, regulatory compliance, and data analysis ensures that studies are conducted with the highest standards of quality and integrity. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Manuel Cuervas-Mons plays a pivotal role in translating scientific discoveries into meaningful healthcare solutions.

Locations

Madrid, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials